Literature DB >> 24220608

Morphology, differentiation and adhesion molecule expression changes of bone marrow mesenchymal stem cells from acute myeloid leukemia patients.

Qiulei Chen1, Yan Yuan, Tong Chen.   

Abstract

Bone marrow mesenchymal stem cells (BMSCs) have been identified as an important component of the hematopoietic stem cell (HSC) niche, which is essential for the maintenance of HSCs. HSC niche alternation has been considered to be the main cause of acute myeloid leukemia (AML). However, little is known with regard to BMSC alteration in AML patients. BMSCs were collected from 10 AML patients and 13 controls in order to examine the morphology, differentiation and adhesion molecule expression changes. It was observed that primary BMSCs from AML patients exhibited aberrant morphologies compared with those from the controls. Prior to adipogenic differentiation, the mRNA and protein levels of the lipid marker gene lipoprotein lipase, from the BMSCs of AML patients, were significantly higher. lipid drops were present early during differentiation in the BMSCs of AML patients and exhibited greater numbers later. Following adipogenic differentiation, the mRNA level of E-cadherin in the BMSCs of AML patients was significantly lower than that identified in the BMSCs of the control groups. Following osteogenic induction, the mRNA level of E-cadherin in the BMSCs of AML patients was significantly higher than in the controls. Therefore BMSCs from the AML patients exhibited irregular morphology, tendency to pre-differentiate to adipocytes and different adhesion molecule expression following differentiation. These differences may further our understanding of the HSC niche in the pathological condition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24220608     DOI: 10.3892/mmr.2013.1789

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  The healing of bone defects by cell-free and stem cell-seeded 3D-printed PLA tissue-engineered scaffolds.

Authors:  Marjan Bahraminasab; Athar Talebi; Nesa Doostmohammadi; Samaneh Arab; Ali Ghanbari; Sam Zarbakhsh
Journal:  J Orthop Surg Res       Date:  2022-06-20       Impact factor: 2.677

2.  Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.

Authors:  Benjamin Roux; Frédéric Picou; Christelle Debeissat; Myriam Koubi; Nathalie Gallay; Pierre Hirsch; Noémie Ravalet; Marie C Béné; Michel Maigre; Mathilde Hunault; Jean Mosser; Amandine Etcheverry; Emmanuel Gyan; François Delhommeau; Jorge Domenech; Olivier Herault
Journal:  Cancer Gene Ther       Date:  2022-02-22       Impact factor: 5.854

3.  Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.

Authors:  S Geyh; M Rodríguez-Paredes; P Jäger; C Khandanpour; R-P Cadeddu; J Gutekunst; C M Wilk; R Fenk; C Zilkens; D Hermsen; U Germing; G Kobbe; F Lyko; R Haas; T Schroeder
Journal:  Leukemia       Date:  2015-11-25       Impact factor: 11.528

Review 4.  CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells.

Authors:  Margot Zöller
Journal:  Front Immunol       Date:  2015-05-26       Impact factor: 7.561

Review 5.  Mesenchymal stromal cells in myeloid malignancies.

Authors:  Thomas Schroeder; Stefanie Geyh; Ulrich Germing; Rainer Haas
Journal:  Blood Res       Date:  2016-12-23

6.  Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response.

Authors:  Xia Sheng; Jonathan Tucci; Jean-Hugues Parmentier; Lingyun Ji; James W Behan; Nora Heisterkamp; Steven D Mittelman
Journal:  Oncotarget       Date:  2016-11-08

Review 7.  Roles of omental and bone marrow adipocytes in tumor biology.

Authors:  Yoon Jin Cha; Ja Seung Koo
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

8.  Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells.

Authors:  Lanxia Zhou; Hong Guo; Fang Jia; Xuan Chen; Xiaowei Zhang; Shouliang Dong; Li Zhao
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.